A detailed history of Ionic Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ionic Capital Management LLC holds 1,200 shares of LLY stock, worth $895,440. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,200
Holding current value
$895,440
% of portfolio
0.21%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $391,444 - $523,697
661 New
661 $514,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ionic Capital Management LLC Portfolio

Follow Ionic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ionic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ionic Capital Management LLC with notifications on news.